UFPT · XBRL financial data

UFP Technologies financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (UFPT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	—	—	—	400,072	504,421	602,797
Cost of goods and services sold	134,689	155,206	263,532	287,847	357,728	432,387
Gross profit	44,684	51,114	90,260	112,225	146,693	170,410
Research and development	8,200	8,500	9,300	7,200	10,400	8,600
Selling, general and administrative	27,493	29,480	45,796	50,889	62,218	77,439
Operating income (loss)	16,732	21,218	55,400	57,664	80,897	92,338
Interest income	0	49	—	—	—	—
Interest expense	83	88	2,763	3,645	8,061	9,804
Other income (expense)	(366)	26	81	(117)	189	(21)
Income tax expense (benefit)	2,914	5,319	10,929	8,978	14,044	14,200
Net income (loss)	13,369	15,886	41,789	44,924	58,981	68,313
Earnings per share, basic USD per share	1.79	2.11	5.52	5.89	7.69	8.87
Earnings per share, diluted USD per share	1.77	2.09	5.45	5.83	7.58	8.75
Weighted average shares, basic thousands of shares	7,484	7,524	7,564	7,624	7,668	7,705
Weighted average shares, diluted thousands of shares	7,568	7,615	7,663	7,701	7,785	7,804

Fiscal years (UFPT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	24,234	11,117	4,451	5,263	13,450	20,301
Accounts receivable	26,428	39,384	55,117	64,449	84,677	82,914
Inventory	18,642	33,436	53,536	70,191	87,536	86,856
Total current assets	71,864	87,320	116,346	144,633	194,945	201,001
Property and equipment, net	53,755	56,569	58,072	62,137	70,564	79,109
Right-of-use asset	2,052	9,053	—	13,437	16,056	18,847
Goodwill	51,838	107,905	113,028	113,263	189,657	197,403
Total assets	203,204	334,132	378,192	404,136	628,995	655,077
Accounts payable	4,121	10,611	19,961	22,286	24,269	24,289
Accrued liabilities	7,944	12,700	23,122	22,085	30,410	28,796
Current portion of long-term debt	0	4,000	4,000	4,000	12,500	12,500
Total current liabilities	15,137	34,706	55,961	58,209	76,295	74,862
Long-term debt	0	71,000	51,000	28,000	176,875	122,955
Lease liability, non-current	950	6,903	—	10,719	12,398	13,988
Total liabilities	26,311	139,686	140,647	118,045	286,235	231,200
Retained earnings	144,921	160,807	202,596	247,520	306,501	374,814
Total stockholders' equity	176,893	194,446	237,545	286,091	342,760	423,877
Total liabilities and equity	203,204	334,132	378,192	404,136	628,995	655,077
Common shares outstanding (cover page) thousands of shares	7,520	7,561	7,610	7,642	7,680	7,713

Fiscal years (UFPT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	13,369	15,886	41,789	44,924	58,981	68,313
Stock-based compensation	1,807	2,428	3,208	4,641	6,842	8,854
Depreciation and amortization	8,268	8,410	11,886	11,407	14,715	19,150
Net cash from operating activities	25,037	14,293	17,744	41,334	66,593	91,905
Purchases of property and equipment	4,368	5,395	13,780	10,490	9,656	—
Net cash from investing activities	(4,261)	(101,459)	1,291	(10,488)	(210,164)	(27,597)
Proceeds from long-term debt	0	40,000	0	0	125,000	0
Repayments of long-term debt	0	0	4,000	4,000	35,125	12,500
Net cash from financing activities	(285)	74,049	(25,894)	(30,024)	152,393	(58,156)
Net change in cash	20,491	(13,117)	(6,666)	812	8,187	6,851

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Ufp Technologies	9,045	173,964	15,612*	7.7M	—	Q2 FY26 10-QJun 30, 2026
Enovis	12,563	582,782	75,032*	57.7M	—	Q2 FY26 10-QJul 3, 2026
Lemaitre Vascular	26,625	not reported	15,965*	22.9M	—	Q2 FY26 10-QJun 30, 2026
AtriCure	167,786	153,604	22,192*	50.9M	—	Q2 FY26 10-QJun 30, 2026
Haemonetics	223,384	339,380	52,323	45.5M	—	Q1 FY27 10-QJun 27, 2026
Teleflex	300,159	570,332	not reported	42.4M	—	Q2 FY26 10-QJun 30, 2026
Artivion	77,316	125,757	(1,266)*	48.8M	61.1 quarters	Q2 FY26 10-QJun 30, 2026
LivaNova	516,619	390,587	66,588*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Envista Holdings	1,125,600	730,500	119,200*	160.6M	—	Q2 FY26 10-QJul 3, 2026

Not investment advice. Not affiliated with the U.S. SEC.